Use of Expression Profiles of HBV-DNA Integrated Into Genomes of Hepatocellular Carcinoma Cells to Select T Cells for Immunotherapy-Reference-Cited by-同舟云学术

Use of Expression Profiles of HBV-DNA Integrated Into Genomes of Hepatocellular Carcinoma Cells to Select T Cells for Immunotherapy

Published:2019-05 Issue:6 Volume:156 Page:1862-1876.e9
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Tan Anthony Tanoto,Yang Ninghan,Lee Krishnamoorthy Thinesh,Oei Vincent^ORCID,Chua Alicia,Zhao Xinyuan,Tan Hui Si,Chia Adeline,Le Bert Nina,Low Diana^ORCID,Tan Hiang Keat^ORCID,Kumar Rajneesh,Irani Farah Gillan,Ho Zi Zong,Zhang Qi,Guccione Ernesto,Wai Lu-En,Koh Sarene,Hwang William^ORCID,Chow Wan Cheng^ORCID,Bertoletti Antonio

Funder

Ministry of Health -Singapore

National Medical Research Council

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference44 articles.

1. The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015;Akinyemiju;JAMA Oncol,2017

2. Tu T, Budzinska MA, Vondran FWR, et al. Hepatitis B virus DNA integration occurs early in the viral life cycle in an in vitro infection model via NTCP-dependent uptake of enveloped virus particles [published online ahead of print February 7, 2018]. J Virol https://doi.org/10.1128/JVI.02007-17

3. Integration of tumour and viral genomic characterizations in HBV-related hepatocellular carcinomas;Amaddeo;Gut,2015

4. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma;Sung;Nat Genet,2012

5. The landscape of viral expression and host gene fusion and adaptation in human cancer;Tang;Nat Commun,2013

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applications of cell therapy in the treatment of virus-associated cancers;Nature Reviews Clinical Oncology;2024-08-19

2. The impact of integrated hepatitis B virus DNA on oncogenesis and antiviral therapy;Biomarker Research;2024-08-15

3. Leveraging oncovirus-derived antigen against the viral malignancies in adoptive cell therapies;Biomarker Research;2024-07-29

4. Altered gut microbiota is associated with the formation of occult hepatitis B virus infection;Microbiology Spectrum;2024-07-02

5. The association between tumour heterogeneity and immune evasion mechanisms in hepatocellular carcinoma and its clinical implications;British Journal of Cancer;2024-05-17